We are live on ! Find out more
CTMX icon

CytomX Therapeutics
CTMX

117 hedge funds and large institutions have $298M invested in CytomX Therapeutics in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

6.03% more ownership

Funds ownership: 79.25% → 85.28% (+6%)

0% less capital invested

Capital invested by funds: $299M → $298M (-$1M)

10% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 41

2% less funds holding

Funds holding: 119 → 117 (-2)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

Holders
117
Holders Change
-2
Holders Change %
-1.68%
% of All Funds
2.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
37
Reduced
41
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$22M
2
Victory Capital Management
Victory Capital Management
Texas
+$19M
3
TCM
Tang Capital Management
California
+$2.09M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.01M
5
GPP
Great Point Partners
Connecticut
+$974K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.52M
2
EC
EcoR1 Capital
California
-$2.85M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.98M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$1.87M
5
Goldman Sachs
Goldman Sachs
New York
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
26
Man Group
United Kingdom
$2.09M -$336K -48,245 -15%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$2.09M +$479K +68,641 +34%
GIM
28
Granahan Investment Management
Massachusetts
$2.04M +$780K +111,855 +73%
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$1.86M +$153K +21,953 +10%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$1.66M -$3.52M -504,436 -70%
Massachusetts Financial Services
31
Massachusetts Financial Services
Massachusetts
$1.6M +$231K +33,069 +19%
Citadel Advisors
32
Citadel Advisors
Florida
$1.55M -$1.63M -233,463 -54%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.5M +$45.9K +6,584 +3%
Two Sigma Investments
34
Two Sigma Investments
New York
$1.37M -$919K -131,777 -42%
SIM
35
Spark Investment Management
New York
$1.36M -$186K -26,607 -13%
JP Morgan Chase
36
JP Morgan Chase
New York
$1.35M -$1.35M -192,992 -52%
PAG
37
Private Advisor Group
New Jersey
$1.08M -$6.97K -1,000 -0.7%
AQR Capital Management
38
AQR Capital Management
Connecticut
$1.08M +$61.2K +8,781 +7%
GPP
39
Great Point Partners
Connecticut
$1.07M +$974K +139,718 New
Goldman Sachs
40
Goldman Sachs
New York
$1.06M -$1.83M -262,407 -66%
CS
41
Credit Suisse
Switzerland
$921K -$39.3K -5,635 -4%
Marshall Wace
42
Marshall Wace
United Kingdom
$900K -$1.98M -284,033 -71%
DCM
43
DAFNA Capital Management
California
$767K – – –
MCM
44
Moore Capital Management
New York
$767K – – –
Connor, Clark & Lunn Investment Management (CC&L)
45
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$763K +$479K +68,673 +223%
CPC
46
Congress Park Capital
New York
$756K +$27.5K +3,950 +4%
Russell Investments Group
47
Russell Investments Group
United Kingdom
$718K +$349K +50,084 +114%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$704K +$16K +2,300 +3%
EAM
49
Exane Asset Management
France
$674K – – –
Swiss National Bank
50
Swiss National Bank
Switzerland
$667K – – –
1
2
3 4 5

CTMX Hedge Fund Activity: Q1 2020 in Review

117 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in CytomX Therapeutics (CTMX) for Q1 2020, worth a combined $298M — down 0.33% from $299M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CTMX and 17 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 37 added.

The largest buyer was BVF Inc, adding an estimated $22M. The largest seller was Point72 Asset Management, cutting an estimated $3.52M.

  • 117 institutional investors held CytomX Therapeutics (CTMX) as of Q1 2020, down from 119 in Q4 2019.
  • Funds reported $298M of CytomX Therapeutics stock for Q1 2020, down 0.33% quarter-over-quarter.
  • 17 funds opened new CytomX Therapeutics positions in Q1 2020 and 19 closed out, a net change of -2 holders.
  • The largest CytomX Therapeutics buyer in Q1 2020 was BVF Inc, an estimated $22M added.
  • The largest CytomX Therapeutics seller in Q1 2020 was Point72 Asset Management, an estimated $3.52M sold.

Based on aggregated 13F filings for Q1 2020.